Clinical Trial Update: Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating palbociclib plus cetuximab versus cetuximab alone for squamous cell carcinoma of the head and neck, completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Cetuximab (cetuximab)
• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Phase 2 | Status: COMPLETED | Results posted: 2019-09-20